无锡药明康德新药开发股份有限公司（股票代码：02359，以下简称“药明康德”）于2026年4月1日发布2026年3月的股份变动月报表，报告期截至2026年3月31日。根据公告，药明康德本月未有新增股份发行、购回或注销活动，各类股本结构保持稳定。
经公告披露，药明康德目前拥有H股510,476,909股和A股2,473,280,246股，合计已发行股本共计2,983,757,155股，面值均为每股人民币1元。对应注册股本总额为人民币2,983,757,155元（约合29.84亿元），与上月保持一致。公司亦无股份期权或股权激励计划的授予、行使或失效情况。
截至2026年3月底，药明康德确认其已满足香港联交所相关规则对公众持股量的要求。公司同时声明将继续遵守各项上市法规和法律规定。
本次公告由公司联席公司秘书张月芬签署，显示药明康德整体股本结构在3月末维持不变。公司方面未披露其他可能影响股本结构或公众持股量的事项。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.